Ausgabe 9/2018
Inhalt (11 Artikel)
Association of CD14-260 (-159) C/T and Alzheimer’s disease: systematic review and trial sequential analyses
Yan Wang, Xiaoling Wu, Xun Deng, Yanjiao Ma, Siyi Huang, Yong Wang
Effects of histone acetyltransferase inhibitors on l-DOPA-induced dyskinesia in a murine model of Parkinson’s disease
Young-Kyoung Ryu, Hye-Yeon Park, Jun Go, Yong-Hoon Kim, Jung Hwan Hwang, Dong-Hee Choi, Jung-Ran Noh, Myungchull Rhee, Pyung-Lim Han, Chul-Ho Lee, Kyoung-Shim Kim
Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson’s disease
S. H. Lee, M. J. Lee, C. H. Lyoo, H. Cho, M. S. Lee
Levodopa-induced dyskinesia in Parkinson’s disease: still no proof? A meta-analysis
Alexandros Giannakis, Maria Chondrogiorgi, Christos Tsironis, Athina Tatsioni, Spiridon Konitsiotis
Comparing incobotulinumtoxinA (Xeomin®) and onabotulinumtoxinA (Botox®): identical potency labelling in the hemidiaphragm assay
Dirk Dressler, Lizhen Pan, Hans Bigalke
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson’s disease
Adjia Hamadjida, Stephen G. Nuara, Jim C. Gourdon, Philippe Huot
Hippocampal subfield atrophy in patients with Parkinson’s disease and psychosis
Abhishek Lenka, Madhura Ingalhalikar, Apurva Shah, Jitender Saini, Shyam Sundar Arumugham, Shantala Hegde, Lija George, Venkateswara Reddy, Y. C. Janardhana Reddy, Ravi Yadav, Pramod Kumar Pal
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy
Tommaso Schirinzi, Giulia Maria Sancesario, Giulia Di Lazzaro, Simona Scalise, Vito Luigi Colona, Paola Imbriani, Nicola Biagio Mercuri, Sergio Bernardini, Anthony E. Lang, Antonio Pisani
Regional alterations of cerebral [18F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats
Nick Van Laeken, Glenn Pauwelyn, Robrecht Dockx, Benedicte Descamps, Boudewijn Brans, Kathelijne Peremans, Chris Baeken, Ingeborg Goethals, Christian Vanhove, Filip De Vos
Investigation into the plasma concentration of ω3 polyunsaturated fatty acids in Japanese attention-deficit hyperactivity disorder patients
Ken Yonezawa, Shunsuke Nonaka, Yuka Iwakura, Yuka Kusano, Yuko Funamoto, Nobukazu Kanchi, Naohiro Yamaguchi, Yuko Kusumoto, Akira Imamura, Hiroki Ozawa
Correction to: Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients
O. Bartošová, C. Bonnet, O. Ulmanová, M. Šíma, F. Perlík, E. Růžička, O. Slanař